Compare TransMedics Group Inc (TMDX) vs Under Armour Inc Class A (UA) Price & Performance

TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.

The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.

Under Armour (UA) trades at $7.13, down 2.06% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of $201.27 million in fiscal 2025, with negative margins and cash flow, though revenue remains substantial at $5.16 billion. Recent news highlights a new Dodge collaboration and an upcoming Q1 2027 earnings call on August 7, 2026.

Outlook is mixed: analyst consensus leans slightly bullish with 40% buy ratings, but fundamental challenges persist including declining revenue projections and negative profitability. Key risks include execution of the business reset and competitive pressures. The stock presents a turnaround opportunity but requires careful monitoring of earnings and margin improvements.